KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Share-based Compensation (2016 - 2026)

Bristol Myers Squibb has reported Share-based Compensation over the past 18 years, most recently at $146.0 million for Q1 2026.

  • Quarterly Share-based Compensation rose 1.39% to $146.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $555.0 million through Mar 2026, up 7.14% year-over-year, with the annual reading at $553.0 million for FY2025, 9.07% up from the prior year.
  • Share-based Compensation was $146.0 million for Q1 2026 at Bristol Myers Squibb, up from $133.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $146.0 million in Q1 2026 and troughed at $107.0 million in Q1 2022.
  • The 5-year median for Share-based Compensation is $129.0 million (2024), against an average of $128.3 million.
  • Year-over-year, Share-based Compensation fell 29.14% in 2022 and then increased 18.1% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $119.0 million in 2022, then increased by 6.72% to $127.0 million in 2023, then decreased by 5.51% to $120.0 million in 2024, then increased by 10.83% to $133.0 million in 2025, then increased by 9.77% to $146.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Share-based Compensation are $146.0 million (Q1 2026), $133.0 million (Q4 2025), and $139.0 million (Q3 2025).